Related Experiment Video

Updated: Aug 19, 2026

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images
04:04

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images

Published on: May 19, 2023

Microphthalmia transcription factor: a specific marker for malignant melanoma

J Vachtenheim1, J Borovanský

  • 1Laboratory of Molecular Biology of the University Hospital Na Bulovce, Charles University in Prague, Czech Republic. jivach@upn.anet.cz

Prague Medical Report
|March 24, 2005
PubMed

Insights

Microphthalmia (MITF) is vital for melanocyte development and survival. This review explores MITF

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Microphthalmia (MITF) is a key transcription factor essential for melanocyte development.
  • MITF regulates pigment cell-specific markers and is crucial for malignant melanocyte survival.
  • Understanding MITF's role is important in cancer research.

Purpose of the Study:

  • To review the potential of MITF as a diagnostic marker for malignant melanoma.
  • To highlight the significance of the melanocyte-specific MITF isoform in tumor diagnosis.

Main Methods:

  • Literature review of studies on MITF function and expression.
  • Analysis of MITF's role in melanocyte biology and melanoma pathogenesis.
  • Evaluation of MITF as a differential diagnostic tool.

Main Results:

  • MITF is indispensable for normal melanocyte formation and survival.
  • MITF plays a critical role in the survival of malignant melanocytes.
  • The melanocyte-specific MITF isoform shows promise as a unique diagnostic marker.

Conclusions:

  • MITF is a crucial factor in melanocyte biology and melanoma.
  • MITF's utility as a marker for malignant melanoma warrants further investigation.
  • The melanocyte-specific MITF isoform may aid in the differential diagnosis of melanocytic tumors.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...